![](/img/cover-not-exists.png)
Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab
Hillas, Georgios, Fouka, Evangelia, Papaioannou, Andriana ILanguage:
english
Journal:
Expert Review of Respiratory Medicine
DOI:
10.1080/17476348.2020.1718495
Date:
January, 2020
File:
PDF, 1.15 MB
english, 2020